Published on in Vol 12 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/50546, first published
.
Cognitive Dysfunction and Affective Mood Disorder Screening in Patients With Chronic Inflammatory Bowel Disease: Protocol for a Prospective Case-Control Study
Cognitive Dysfunction and Affective Mood Disorder Screening in Patients With Chronic Inflammatory Bowel Disease: Protocol for a Prospective Case-Control Study
Journals
- Gong G, Xu C, Zhang Z, Zheng Y. Association between depression and anxiety with the risk and flare of inflammatory bowel disease: a systematic review and meta-analysis. Internal and Emergency Medicine 2025;20(1):35 View
- Sârb O, Iacobescu M, Soporan A, Mureșan X, Sârb A, Stănciulescu R, Leucuța C, Tanțău A. Brain-Gut Interplay: Cognitive Performance and Biomarker Correlations in IBD Patients. Journal of Clinical Medicine 2025;14(7):2293 View
- Kumar G, Yadav S, Dwivedi S, Sharma A, Kosey S. The gut-brain connection in inflammatory bowel disease: Mechanisms, mental health, and therapeutic horizons. Gastroenterology & Endoscopy 2026;4(2):141 View
- Song J, Wu R, Sun R, Gao Y, He B, Xie Y, Xie J, Li X, Tong F, Liu Y, Li H, Wang Z. Gastrodin alleviates acute colitis with comorbid anxiety- and depression-like behaviours rather than cognitive dysfunction by modulating gut microbiota and suppressing inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology 2026 View